Inventor · disambiguated record
Robert P. Rehfuss
Also filed as: REHFUSS ROBERT P
10 granted patents·1 pending application·73 citations·filing 2005–2021
89Inventor score
Files withBRISTOL MYERS SQUIBB CO11
Top patents by PatentIndex Score
11 records- 0194US8895010B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 25, 2014·24 cites·36 claims
- 0291US9228018B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·11 cites·35 claims
- 0388US9765150B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 19, 2017·5 cites·37 claims
- 0488US8981072B2Nucleic acids encoding antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 17, 2015·8 cites·27 claims
- 0587US7470712B2Amino-benzazoles as P2Y1 receptor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 30, 2008·10 cites·18 claims
- 0683US7388021B2Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·8 cites·18 claims
- 0779US8053450B2Amino-benzazoles as P2Y1 receptor inhibitors with pyridine ring and heterocyclic componentsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Nov 8, 2011·3 cites·14 claims
- 0878US10196451B2Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40LBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 0978US2022073636A1Antibody polypeptides that antagonize cd40lBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 1077US7674828B2Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 9, 2010·3 cites·8 claims
- 1171US11180567B2Antibody polypeptides that antagonize CD40LBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 23, 2021·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Robert P. Rehfuss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →